Evolution step-up growth trajectory upward trajectory
Pharma

How biosimilar developers are embracing next phase of US market

Although the so-called biosimilar ‘void’ could pose challenges to upcoming biosimilar availability, the opportunity it presents is also immense.
Downward arrow superimposed in front of money

AstraZeneca, Ionis shares slide with ATTR-CM trial failure

Jul 9, 2026 11:36am
Vaccines

HHS proposes creating table of COVID vaccine injuries

Jul 9, 2026 11:08am
migraine headache

Ipsen’s Botox rival Dysport posts dual ph. 3 wins in migraine

Jul 9, 2026 10:36am
women gender womens health International Womens Day

Allergan Aesthetics, Girls Inc. help map paths for women in STEM

Jul 8, 2026 8:47pm
Sanofi

Sanofi offers commitments to end EU flu shot antitrust probe

Jul 8, 2026 4:26pm
More News

Lundbeck hit with untitled letter over Vyepti efficacy claims

Jul 8, 2026 4:23pm

CureDuchenne shines a light on birthdays for DMD patients

Jul 8, 2026 1:49pm
Fierce Biotech

FDA halts release of new drug rejection letters

Jul 8, 2026 1:33pm

Drugmaker caught faking doctors’ petition to evade China price cut

Jul 8, 2026 11:31am